Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Gross Margin (2021 - 2025)

HeartSciences filings provide 5 years of Gross Margin readings, the most recent being 58.33% for Q4 2025.

  • On a quarterly basis, Gross Margin changed N/A to 58.33% in Q4 2025 year-over-year; TTM through Jan 2026 was 57.92%, a 939.0% decrease, with the full-year FY2025 number at 56.78%, down 1052.0% from a year prior.
  • Gross Margin hit 58.33% in Q4 2025 for HeartSciences, down from 60.0% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 69.15% in Q2 2022 to a low of 23.09% in Q3 2021.
  • Median Gross Margin over the past 5 years was 60.51% (2025), compared with a mean of 56.36%.
  • Biggest five-year swings in Gross Margin: surged 1329bps in 2022 and later plummeted -781bps in 2023.
  • HeartSciences' Gross Margin stood at 23.09% in 2021, then soared by 58bps to 36.38% in 2022, then surged by 68bps to 61.03% in 2023, then grew by 13bps to 68.97% in 2024, then decreased by -15bps to 58.33% in 2025.
  • The last three reported values for Gross Margin were 58.33% (Q4 2025), 60.0% (Q3 2025), and 56.78% (Q2 2025) per Business Quant data.